Evidence map›Paper›PMID 40002232›Full record

ReviewCancers2025

Neoadjuvant Immunotherapy in Cutaneous Squamous Cell Carcinoma: Systematic Literature Review and State of the Art.

Marco Spadafora, Alessia Paganelli, Margherita Raucci, Shaniko Kaleci, Ketty Peris, Stefania Guida, Giovanni Pellacani, Caterina Longo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marco SpadaforaAzienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, Skin Cancer Center, 42122 Reggio Emilia, Italy.ORCID 0000-0003-3509-4222
Alessia PaganelliIDI-IRCCS Istituto Dermopatico dell'Immacolata, 00167 Rome, Italy.ORCID 0000-0002-0916-7769
Margherita RaucciAzienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, Skin Cancer Center, 42122 Reggio Emilia, Italy.
Shaniko KaleciDepartment of Surgery, Medicine, Dental Medicine and Morphological Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.ORCID 0000-0002-1166-2961
Ketty PerisDermatology Unit, Department of Surgical and Medical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
Stefania GuidaSchool of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy.
Giovanni PellacaniDepartment of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Dermatology Clinic, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-7222-2951
Caterina LongoAzienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, Skin Cancer Center, 42122 Reggio Emilia, Italy.ORCID 0000-0002-8218-3896

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous squamous cell carcinoma (cSCC) is the second most common type of skin cancer globally, accounting for 20% to 50% of all skin cancers [...].

Indexed as

cSCCimmunotherapyneoadjuvantnon-melanoma skin canceroncologyskin cancersquamous cell carcinomatherapy

Identifiers

PMID40002232
PMCPMC11852655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.